Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.

Brudner RM, Kaczmarek E, Blainey MG, Schulz-Quach C, Meshkat S, Doyle Z, Lipsitz O, Offman H, Sethi R, Weiglein G, McIntyre RS, Rosenblat JD

Open source

DOI
10.1177/02698811251346697
Published
2025 Sep
Container
Journal of psychopharmacology (Oxford, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/02698811251346697,
  title = {Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.},
  author = {Brudner RM and Kaczmarek E and Blainey MG and Schulz-Quach C and Meshkat S and Doyle Z and Lipsitz O and Offman H and Sethi R and Weiglein G and McIntyre RS and Rosenblat JD},
  year = {2025},
  journal = {Journal of psychopharmacology (Oxford, England)},
  doi = {10.1177/02698811251346697},
  url = {https://doi.org/10.1177/02698811251346697}
}

RIS

TY  - JOUR
TI  - Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.
AU  - Brudner RM
AU  - Kaczmarek E
AU  - Blainey MG
AU  - Schulz-Quach C
AU  - Meshkat S
AU  - Doyle Z
AU  - Lipsitz O
AU  - Offman H
AU  - Sethi R
AU  - Weiglein G
AU  - McIntyre RS
AU  - Rosenblat JD
PY  - 2025
JO  - Journal of psychopharmacology (Oxford, England)
DO  - 10.1177/02698811251346697
UR  - https://doi.org/10.1177/02698811251346697
ER  - 

APA

RM, B., E, K., MG, B., C, S., S, M., Z, D., O, L., H, O., R, S., G, W., RS, M., & JD, R. (2025). Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.. Journal of psychopharmacology (Oxford, England). https://doi.org/10.1177/02698811251346697

Source records